Shanghai Soho-Yiming Pharmaceuticals

GMP peptide API enterprise in Shanghai and wholly owned subsidiary of Ankebio. Passed FDA on-site inspection with no deficiencies in 2017; holds 6 peptide GMP approvals plus CEPs for Oxytocin and Salmon Calcitonin. 60+ peptide APIs in market or clinical stages with approximately 500kg annual capacity.

Directory assessment: Shanghai Soho-Yiming Pharmaceuticals is listed as a manufacturer in the peptide supply chain, serving Asia markets from China (Shanghai). As a direct manufacturer, this supplier controls its own production process from synthesis through purification and quality control release testing. This profile lists 2 sources for reference. This supplier has a strong confidence score, indicating a high level of verification and reliability for B2B sourcing.